Blockbuster Anticlotting Drug Approved on Flawed Studies
- Ticagrelor, a blockbuster anticlotting drug, was approved despite FDA scientists warning it looked less safe and effective than older, cheaper alternatives like clopidogrel
- The landmark PLATO trial used to secure approval showed U.S. patients had worse outcomes on ticagrelor, yet those results were overridden by FDA leadership
- Investigations revealed serious problems with the trial, including altered death records, missing data, and inconsistent monitoring that favored ticagrelor
- Follow-up platelet studies were also misreported, with non-significant results published as significant and some listed authors denying participation
- Knowing these flaws allows you to ask about proven alternatives, reduce your personal heart risk through lifestyle, and avoid dependence on drugs pushed forward with weak, flawed evidence
You May Also Like

The Reality Revolution Podcast
Brian Scott

The Omni Dental & Medspa Podcast
Dr. Bilus Poles

Good Thinking: Positive Affirmations
Just Curious Media

The Anxiety Coaches Podcast
Gina Ryan

Daily Meditation
Daily Meditation Club

The Real Truth About Health Free 17 Day Live Online Conference Podcast
Lloyd Burrell, Keith Block M.D., Jeffrey Smith, Michael Klaper M.D., Ralph Moss, Brenda Davis R.D., Mark Sloan, Gerald Posner, Ian Harris M.D., Neil Barnard M.D., Will Tuttle Ph.D., John McDougall M.D., Pam Popper Ph.D., Gabriel Cousens M.D., Brian Clement Ph.D., Anna Maria Clement Ph.D., Marianne W
Let me bore you to sleep
Jason Newland

Strictly Anonymous Confessions
Kathy Kay

Let me bore you to sleep - Jason Newland
Jason Newland

Hypnosis for sleeping deeply (Jason Newland)
Jason Newland
Community discussion